Don’t Reveal Patients’ Safety Data Just Because They Have, Trial Sponsors Told
Executive Summary
A transparency consultant says companies should not be pressured into revealing sensitive safety data under clinical trial transparency initiatives even if this information is made available by trial participants themselves on social media sites.